KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EBITDA (2016 - 2025)

Incyte's EBITDA history spans 16 years, with the latest figure at $335.9 million for Q4 2025.

  • For Q4 2025, EBITDA rose 11.39% year-over-year to $335.9 million; the TTM value through Dec 2025 reached $1.5 billion, up 2368.56%, while the annual FY2025 figure was $1.5 billion, 2368.56% up from the prior year.
  • EBITDA reached $335.9 million in Q4 2025 per INCY's latest filing, down from $443.5 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $530.3 million in Q2 2025 to a low of -$478.1 million in Q2 2024.
  • Average EBITDA over 5 years is $168.1 million, with a median of $166.7 million recorded in 2023.
  • Peak YoY movement for EBITDA: surged 4320.02% in 2021, then tumbled 346.74% in 2024.
  • A 5-year view of EBITDA shows it stood at $110.7 million in 2021, then crashed by 36.7% to $70.1 million in 2022, then skyrocketed by 167.17% to $187.3 million in 2023, then skyrocketed by 61.0% to $301.5 million in 2024, then grew by 11.39% to $335.9 million in 2025.
  • Per Business Quant, the three most recent readings for INCY's EBITDA are $335.9 million (Q4 2025), $443.5 million (Q3 2025), and $530.3 million (Q2 2025).